NANOVIRICIDES, INC. Common Stock, Value, Issued
NANOVIRICIDES, INC. (NNVC) had Common Stock, Value, Issued of $216 as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-05-15
- 2026-03-31: Common Stock, Value, Issued $216.00.
- 2025-12-31: Common Stock, Value, Issued $216.00.
- 2025-09-30: Common Stock, Value, Issued $176.00.
- 2025-06-30: Common Stock, Value, Issued $166.00.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-03-31 | $216.00 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $216.00 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $176.00 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $166.00 10-Q · filed 2026-05-15 | |
| 2025-03-31 | $160.00 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $156.00 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $140.00 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $131.00 10-K · filed 2025-09-29 | |
| 2024-03-31 | $118.00 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $117.00 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $117.00 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $117.00 10-K · filed 2024-09-27 | $116.00 10-K · filed 2023-10-13 |
| 2023-03-31 | $11.67K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $11.63K 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $11.61K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $116.00 10-K · filed 2023-10-13 | $11.59K 10-K · filed 2022-10-13 |
| 2022-03-31 | $11.55K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $11.53K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $11.53K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $11.52K 10-K · filed 2022-10-13 | |
| 2021-03-31 | $11.51K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $10.68K 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $10.67K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $9.08K 10-K · filed 2021-10-12 | |
| 2020-03-31 | $7.67K 10-Q · filed 2020-06-22 | |
| 2019-12-31 | $3.87K 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $3.85K 10-Q · filed 2019-11-15 | |
| 2019-06-30 | $3.85K 10-K · filed 2020-10-13 | $76.90K 10-K · filed 2019-08-23 |
| 2019-03-31 | $76.73K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $69.50K 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $69.38K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $69.17K 10-K · filed 2019-08-23 | |
| 2018-03-31 | $68.98K 10-Q · filed 2018-05-21 | |
| 2017-12-31 | $63.37K 10-Q · filed 2018-02-20 | |
| 2017-09-30 | $63.33K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $63.31K 10-K · filed 2018-10-12 | $63.30K 10-K · filed 2017-09-28 |
| 2017-03-31 | $63.07K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $58.46K 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $58.20K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $58.18K 10-K · filed 2017-09-28 | |
| 2016-03-31 | $57.97K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $57.82K 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $57.59K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $57.24K 10-K · filed 2016-09-16 | |
| 2015-03-31 | $57.15K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $56.56K 10-Q · filed 2015-02-25 | |
| 2014-09-30 | $56.53K 10-Q/A · filed 2015-02-23 | |
| 2014-06-30 | $54.62K 10-K · filed 2015-09-14 | |
| 2014-03-31 | $54.54K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $50.04K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $50.03K 10-Q/A · filed 2015-02-23 | |
| 2013-06-30 | $47.03K 10-K · filed 2015-02-23 | |
| 2013-03-31 | $164.57K 10-Q/A · filed 2013-05-20 | |
| 2012-12-31 | $160.94K 10-Q/A · filed 2013-02-22 | |
| 2012-09-30 | $158.42K 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $44.46K 10-K/A · filed 2013-10-08 | $155.65K 10-K/A · filed 2012-10-26 |
| 2012-03-31 | $153.66K 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $149.80K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $145.76K 10-Q/A · filed 2011-12-12 | |
| 2011-06-30 | $143.58K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |